Evidence map›Paper›PMID 29504907›Full record

ArticleBMC genomics2018

HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer.

Elena A Pudova, Anna V Kudryavtseva, Maria S Fedorova, Andrew R Zaretsky, Dmitry S Shcherbo, Elena N Lukyanova, Anatoly Y Popov, Asiya F Sadritdinova, Ivan S Abramov, Sergey L Kharitonov and 13 more

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Essential role of aerobic glycolysis in epithelial-to-mesenchymal transition during carcinogenesis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 1 country.

Elena A PudovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Anna V KudryavtsevaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Maria S FedorovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Andrew R ZaretskyPirogov Russian National Research Medical University, Moscow, Russia.
Dmitry S ShcherboPirogov Russian National Research Medical University, Moscow, Russia.
Elena N LukyanovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Anatoly Y PopovPletnev State Hospital, Moscow, Russia.
Asiya F SadritdinovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Ivan S AbramovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Sergey L KharitonovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
George S KrasnovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Kseniya M KliminaVavilov Institute of General Genetics, Russian Academy of Sciences Moscow, Moscow, Russia.
Nadezhda V KorobanNational Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia.
Nadezhda N VolchenkoNational Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia.
Kirill M NyushkoNational Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia.
Nataliya V MelnikovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Maria A ChernichenkoNational Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia.
Dmitry V SidorovNational Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia.
Boris Y AlekseevNational Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia.
Marina V KiselevaNational Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia.
Andrey D KaprinNational Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia.
Alexey A DmitrievEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Anastasiya V SnezhkinaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia. leftger@rambler.ru.
Engelhardt Institute of Molecular Biology · RUMinistry of Health of the Russian Federation · RUPirogov Russian National Research Medical University · RUVavilov Institute of General Genetics · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) is a common cancer worldwide. The main cause of death in CRC includes tumor progression and metastasis. At molecular level, these processes may be triggered by epithelial-mesenchymal transition (EMT) and necessitates specific alterations in cell metabolism. Although several EMT-related metabolic changes have been described in CRC, the mechanism is still poorly understood.

resultsUsing CrossHub software, we analyzed RNA-Seq expression profile data of CRC derived from The Cancer Genome Atlas (TCGA) project. Correlation analysis between the change in the expression of genes involved in glycolysis and EMT was performed. We obtained the set of genes with significant correlation coefficients, which included 21 EMT-related genes and a single glycolytic gene, HK3. The mRNA level of these genes was measured in 78 paired colorectal cancer samples by quantitative polymerase chain reaction (qPCR). Upregulation of HK3 and deregulation of 11 genes (COL1A1, TWIST1, NFATC1, GLIPR2, SFPR1, FLNA, GREM1, SFRP2, ZEB2, SPP1, and RARRES1) involved in EMT were found. The results of correlation study showed that the expression of HK3 demonstrated a strong correlation with 7 of the 21 examined genes (ZEB2, GREM1, TGFB3, TGFB1, SNAI2, TWIST1, and COL1A1) in CRC.

conclusionsUpregulation of HK3 is associated with EMT in CRC and may be a crucial metabolic adaptation for rapid proliferation, survival, and metastases of CRC cells.

Indexed as

Colorectal NeoplasmsEpithelial-Mesenchymal TransitionFemaleGene Expression ProfilingGenomicsHexokinaseHumansMaleMiddle AgedUp-RegulationHexokinaseColorectal cancerEpithelial-mesenchymal transitionGlycolysisHexokinaseWarburg effect

Identifiers

PMID29504907
PMCPMC5836836
OpenAlexW2788403588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.